AbbVie and Turnstone Biologics announce global collaboration on viral immunotherapies in oncology
- Details
- Category: AbbVie
AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Turnstone Biologics, a clinical-stage immuno-oncology company, have announced a research, option and license agreement whereby AbbVie obtained an exclusive option to license up to three of Turnstone's next-generation oncolytic viral immunotherapies.
Pfizer reviewing strategic alternatives for Consumer Healthcare business
- Details
- Category: Pfizer
Pfizer Inc. is reviewing strategic alternatives for its Consumer Healthcare business. A range of options will be considered, including a full or partial separation of the Consumer Healthcare business from Pfizer through a spin-off, sale or other transaction, and Pfizer may ultimately determine to retain the business. This announcement is part of Pfizer's continuing efforts to allocate resources and capital to best serve patients and maximize value for its shareholders.
Tagrisso granted breakthrough therapy designation by US FDA for the 1st-line treatment of patients with EGFR mutation-positive non-small cell lung cancer
- Details
- Category: AstraZeneca
AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Tagrisso (osimertinib) for the 1st-line treatment of patients with metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).
Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams
- Details
- Category: Roche
Roche (SIX: RO, ROG; OTCQX:RHHBY), has announced the launch of the NAVIFY Tumor Board solution, a clinical workflow and decision support software that optimises decision-making for cancer patient case reviews in tumor boards, or multi-disciplinary team meetings. The solution fundamentally changes the way these meetings are organised and conducted.
Pfizer launches novel programs to put important support services at the fingertips of cancer patients
- Details
- Category: Pfizer
Pfizer today unveils enhanced offerings to help patients manage their life with cancer. Pfizer Oncology Together is a first-of-its-kind program for patients taking Pfizer Oncology medicines that offers dedicated social workers called 'Care Champions' to help navigate the complexities that accompany treatment, such as identifying resources to help find emotional support, and workplace transition, transportation and financial assistance.
Caregivers wish liver cancer received greater public awareness in the U.S., new survey reveals
- Details
- Category: Bristol-Myers Squibb
Bristol-Myers Squibb Company (NYSE:BMY), in collaboration with Blue Faery: The Adrienne Wilson Liver Cancer Association, a leading liver cancer patient advocacy organization, today announced the findings from a new survey exploring the experiences of caregivers of people living with early or advanced stage liver cancer in the U.S.
Amgen and CytomX Therapeutics announce strategic collaboration in immuno-oncology
- Details
- Category: Amgen
Amgen (NASDAQ:AMGN) and CytomX Therapeutics, Inc., (NASDAQ:CTMX) today announced that the companies have entered into a strategic collaboration in immuno-oncology. The companies will co-develop a CytomX ProbodyTM T-cell engaging bispecific against the Epidermal Growth Factor Receptor (EGFR), a highly validated oncology target expressed on multiple human cancer types.
More Pharma News ...
- Abbott acquisition of Alere set to close on Tuesday, October 3, 2017
- IDF and Novo Nordisk launch first-ever global survey on cardiovascular disease awareness among people with type 2 diabetes
- Novartis and UC Berkeley collaborate to tackle 'undruggable' disease targets
- Amgen and Simcere announce strategic collaboration to co-develop and commercialize biosimilars in China
- Up to $20,000 available to the digital health company that solves one of the challenges proposed by MSD
- Daiichi Sankyo announces TaNeDS Global 2018 collaborative drug discovery program
- Bevespi Aerosphere demonstrates statistically significant improvement in lung function in patients with COPD